Fluvastatin enhances healing of medication-related osteonecrosis of the jaw (MRONJ) via macrophage polarization in a rat MRONJ-like model. [PDF]
Tazaki M +5 more
europepmc +1 more source
Medication-related osteonecrosis of the jaw in an adult with osteogenesis imperfecta: a case report. [PDF]
Zhu WY, Wan W, Wu PA, Zhou LW.
europepmc +1 more source
Medication-Related Osteonecrosis of the Jaw in a Patient With Prostate Cancer: A Case Presentation With a One-Month Follow-Up. [PDF]
Kachouh CF +5 more
europepmc +1 more source
Anatomical and Systemic Risk Factors for Recurrence in Medication-Related Osteonecrosis of the Jaw (MRONJ): A Retrospective Study of 812 Patients. [PDF]
Park KC, Kim HJ, Oh JS, Moon SY.
europepmc +1 more source
Incidental Mandibular FDG Uptake on PET/CT Preceding Medication-Related Osteonecrosis of the Jaw in a Patient Receiving High-Dose Denosumab: A Case Report. [PDF]
Sakamoto Y, Sawada S, Umeda M, Kojima Y.
europepmc +1 more source
Identifying the clinical indicator for surgical intervention in medication-related osteonecrosis of the jaw. [PDF]
Tadokoro Y +7 more
europepmc +1 more source
Asia-Pacific consensus statement on medication-related osteonecrosis of the jaw in patients with osteoporosis. [PDF]
Taguchi A +31 more
europepmc +1 more source
Association between periodontal disease severity and the risk of medication-related osteonecrosis of the jaw: a systematic review and meta-analysis by the Korean Academy of Periodontology. [PDF]
Lee JH +6 more
europepmc +1 more source
Medication-related osteonecrosis of the jaw in breast cancer patients: a longitudinal observational Swedish study of oral health and antiresorptive use. [PDF]
Korytowska M +4 more
europepmc +1 more source

